Best Practice & Research Clinical Rheumatology
Volume 22, Issue 4 , Pages 759-772 , August 2008

Prevention of musculoskeletal conditions in the developing world

  • Anthony D. Woolf, BSc, MBBS, FRCP (Professor)

      Affiliations

    • Corresponding Author InformationCorresponding author. Duke of Cornwall Department of Rheumatology, Royal Cornwall Hospital, Truro, TR1 3LJ, UK.
  • Girish M. Mody, MBChB (Natal), FRCP (London), MD (Cape Town), FCP (SA) (Professor, Fellow of the University of Kwa Zulu-Natal, and Aaron Beare Family Professor of Rheumatology)

References 

  1. Woolf AD. The bone and joint decade 2000–2010. Annals of the Rheumatic Diseases. 2000;59(2):81–82
  2. Preventing chronic diseases. A vital investment. A WHO Global Report. Geneva, Switzerland: World Health Organisation; 2005;Available from: http://www.who.int/chp/chronic_disease_report/contents/en/index.html
  3. Gaining Health. The European Strategy for Prevention and Control of Noncommunicable Diseases. Report of the 56th Session of the WHO Europe Regional Committee for Europe, Copenhagen, 11–14 September 2006. Available from: http://www.euro.who.int/Document/RC56/edoc08.pdf.
  4. Global Burden of Disease and Risk Factors. The World Bank, Washington DC: Oxford University Press and the World Bank; 2006;ISBN-10: 0-8213-6262-3
  5. Connelly LB, Woolf AD, Brooks P. Cost effectiveness of interventions for musculoskeletal conditions. In:  Jamison DT,  Bremen JG,  Measham AR,  Alleyne G,  Claeson M,  Evans DB editor. Disease control priorities in developing countries. New York: The World Bank and Oxford University Press; 2006;p. 963–980
  6. Woolf AD, Pfleger B. Burden of major musculoskeletal conditions. Bulletin of the World Health Organization. 2003;81(9):646–656
  7. Muirden KD. Community Oriented Program for the Control of Rheumatic Diseases: studies of rheumatic diseases in the developing world. Current Opinion in Rheumatology. 2005;17(2):153–156
  8. Darmawan J, Valkenburg HA, Muirden KD, Wigley RD. The epidemiology of gout and hyperuricemia in a rural population of Java. The Journal of Rheumatology. 1992;19(10):1595–1599
  9. Minaur N, Sawyers S, Parker J, Darmawan J. Rheumatic disease in an Australian Aboriginal community in North Queensland, Australia. A WHO-ILAR COPCORD survey. The Journal of Rheumatology. 2004;31(5):965–972
  10. Klemp P, Stansfield SA, Castle B, Robertson MC. Gout is on the increase in New Zealand. Annals of the Rheumatic Diseases. 1997;56(1):22–26
  11. Rosenstock L, Cullen M, Fingerhut M. Occupational health. In:  Jamison DT,  Breman JG,  Measham AR,  Alleyne G,  Claeson M,  Evans DB editor. Disease control priorities project in developing countries. Washington, DC: The World Bank and Oxford University Press; 2006;p. 1127–1145
  12. The International Classification of Functioning and Health (ICF). Geneva: World Health Organization; 2001;
  13. Woolf AD. The global perspective of osteoporosis: the ILAR lecture, June 2004, Berlin. Clinical Rheumatology. 2006;25(5):613–618
  14. Obesity and overweight. WHO fact sheet 311. 2006;Available from: http://www.who.int/mediacentre/factsheets/fs311/en/print.html
  15. Physical inactivity: a global problem. WHO fact sheet. 2004;Available from: http://www.who.int/dietphysicalactivity/factsheet_inactivity/en/print.html
  16. Jha P, Chaloupka FJ, Moore J, et al. Tobacco addiction. In:  Jamison DT,  Breman JG,  Measham AR,  Alleyne G,  Claeson M,  Evans DB editor. Disease control priorities in developing countries. 2nd ed.. Washington, DC: The World Bank and Oxford University Press; 2006;p. 869–885
  17. Rehm J, Chisholm D, Room R, Lopez AD. Alcohol. In:  Jamison DT,  Breman JG,  Measham AR,  Alleyne G,  Claeson M,  Evans DB editor. disease control priorities in developing countries. 2nd ed.. Washington, DC: The World Bank and Oxford University Press; 2006;p. 887–907
  18. European action towards better musculoskeletal health. Lund, Sweden: Bone and Joint Decade; 2004;Available from: http://europa.eu.int/comm/health/ph_projects/2000/promotion/fp_promotion_2000_exs_15_en.pdf
  19. Wilson JMG, Jungner G. Principles and practice of screening for disease. Geneva: World Health Organization; 1968;
  20. Criteria for appraising the viability, effectiveness and appropriateness of a screening programme. UK National Screening Committee; 2003;Available from: http://www.nsc.nhs.uk/uk_nsc/uk_nsc_ind.htm
  21. Darmawan J, Muirden KD. WHO-ILAR COPCORD perspectives past, present, and future. The Journal of Rheumatology. 2003;30(11):2312–2314
  22. Woolf AD, Akesson K. Strategies for the prevention and management of musculoskeletal conditions. Best Practice & Research Clinical Rheumatology. 2007;21(1):1–220
  23. Barlow J, Wright C, Sheasby J, et al. Self-management approaches for people with chronic conditions: a review. Patient Education and Counseling. 2002;48(2):177–187
  24. Bergman S. Management of musculoskeletal pain. Best Practice & Research. Clinical Rheumatology. 2007;21(1):153–166
  25. The European health report. Public health action for healthier children and populations. WHO Regional Office for Europe; 2005;Available from: http://www.euro.who.int/document/e87325.pdf
  26. Woolf AD, Breedveld F, Kvien TK. Controlling the obesity epidemic is important for maintaining musculoskeletal health. Annals of the Rheumatic Diseases. 2006;65(11):1401–1402
  27. The World Health Report 2002-reducing risks, promoting healthy life. WHO Regional Office for Europe; 2002;Available from: http://www.who.int/whr/2002/en/whr02_en.pdf
  28. The FRAX tool . World Health Organization Collaborating Centre for Metabolic Bone Diseases. UK: University of Sheffield; 2008;Available from: http://www.shef.ac.uk/FRAX/
  29. Rantapaa-Dahlqvist S, de Jong BA, Berglin E, et al. Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. Arthritis and Rheumatism. 2003;48(10):2741–2749
  30. Combe B, Landewe R, Lukas C, et al. EULAR recommendations for the management of early arthritis: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Annals of the Rheumatic Diseases. 2007;66(1):34–45
  31. Woolf AD, Zeidler H, Haglund U, et al. Musculoskeletal pain in Europe: its impact and a comparison of population and medical perceptions of treatment in eight European countries. Annals of the Rheumatic Diseases. 2004;63(4):342–347
  32. Akesson K, Dreinhofer KE, Woolf AD. Improved education in musculoskeletal conditions is necessary for all doctors. Bulletin of the World Health Organization. 2003;81(9):677–683
  33. The burden of musculoskeletal diseases at the start of the new millenium. Report of a WHO Scientific Group. TRS 919 WHO Technical Report Series. Vol. 919. Geneva, Switzerland: World Health Organization; 2003;Available from: http://whqlibdoc.who.int/trs/WHO_TRS_919.pdf
  34. Willett WC, Koplan JP, Nugent R, et al. Prevention of chronic disease by means of diet and lifestyle changes. In:  Jamison DT,  Breman JG,  Measham AR,  Alleyne G,  Claeson M,  Evans DB editor. Disease control priorities in developing countries. Washington, DC: The World Bank and Oxford University Press; 2006;p. 833–850
  35. Woolf AD, Walsh NE, Akesson K. Global core recommendations for a musculoskeletal undergraduate curriculum. Annals of the Rheumatic Diseases. 2004;63(5):517–524

PII: S1521-6942(08)00075-2

doi: 10.1016/j.berh.2008.07.003

Best Practice & Research Clinical Rheumatology
Volume 22, Issue 4 , Pages 759-772 , August 2008

Article Tools

* Image Usage & Resolution